These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22112552)

  • 1. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
    Beach TG; Sue LI; Walker DG; Sabbagh MN; Serrano G; Dugger BN; Mariner M; Yantos K; Henry-Watson J; Chiarolanza G; Hidalgo JA; Souders L
    J Alzheimers Dis; 2012; 28(4):869-76. PubMed ID: 22112552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of Alzheimer's disease: a critical update.
    Jellinger KA; Bancher C
    J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
    Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
    J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
    Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
    J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation.
    Arias JC; Edwards M; Vitali F; Beach TG; Serrano GE; Weinkauf CC
    J Vasc Surg; 2022 Jan; 75(1):223-228. PubMed ID: 34478810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
    Nelson PT; Abner EL; Schmitt FA; Kryscio RJ; Jicha GA; Santacruz K; Smith CD; Patel E; Markesbery WR
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):774-84. PubMed ID: 19535994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle-only dementia): the Hisayama Study.
    Noda K; Sasaki K; Fujimi K; Wakisaka Y; Tanizaki Y; Wakugawa Y; Kiyohara Y; Iida M; Aizawa H; Iwaki T
    Neuropathology; 2006 Dec; 26(6):508-18. PubMed ID: 17203586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of clinical and preclinical Alzheimer's disease.
    Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
    Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms.
    Malpas CB; Sharmin S; Kalincik T
    Int J Neurosci; 2021 Aug; 131(8):800-809. PubMed ID: 32303140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.
    Mufson EJ; Malek-Ahmadi M; Perez SE; Chen K
    Neurobiol Aging; 2016 Jan; 37():147-153. PubMed ID: 26686670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.
    Dugger BN; Serrano GE; Sue LI; Walker DG; Adler CH; Shill HA; Sabbagh MN; Caviness JN; Hidalgo J; Saxon-Labelle M; Chiarolanza G; Mariner M; Henry-Watson J; Beach TG;
    J Parkinsons Dis; 2012 Jan; 2(1):57-65. PubMed ID: 22924088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
    Beach TG; Thal DR; Zanette M; Smith A; Buckley C
    J Alzheimers Dis; 2016 Mar; 52(3):863-73. PubMed ID: 27031469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
    Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment.
    Marx GA; Koenigsberg DG; McKenzie AT; Kauffman J; Hanson RW; Whitney K; Signaevsky M; Prastawa M; Iida MA; White CL; Walker JM; Richardson TE; Koll J; Fernandez G; Zeineh J; Cordon-Cardo C; Crary JF; Farrell K;
    Acta Neuropathol Commun; 2022 Oct; 10(1):157. PubMed ID: 36316708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females.
    Wang YT; Therriault J; Servaes S; Tissot C; Rahmouni N; Macedo AC; Fernandez-Arias J; Mathotaarachchi SS; Benedet AL; Stevenson J; Ashton NJ; Lussier FZ; Pascoal TA; Zetterberg H; Rajah MN; Blennow K; Gauthier S; Rosa-Neto P;
    Brain; 2024 Apr; 147(4):1497-1510. PubMed ID: 37988283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
    Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
    Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.